Old Web
English
Sign In
Acemap
>
authorDetail
>
R W M Pauwels
R W M Pauwels
Erasmus University Rotterdam
Medicine
Internal medicine
Physical therapy
Diabetes mellitus
Gastroenterology
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
2021
Inflammatory Bowel Diseases
R W M Pauwels
Elisa Proietti
Christien J. van der Woude
Lindsey Oudijk
Marie-Rose B. S. Crombag
Maikel P. Peppelenbosch
Ursula Grohmann
Gwenny M. Fuhler
Annemarie C. de Vries
Show All
Source
Cite
Save
Citations (0)
Lengthening adalimumab dosing interval in quiescent Crohn's disease patients: protocol for the pragmatic randomised non-inferiority LADI study.
2020
BMJ Open
Lisa J.T. Smits
R W M Pauwels
Wietske Kievit
Dirk J. de Jong
A. C. de Vries
Frank Hoentjen
C.J. van der Woude
Show All
Source
Cite
Save
Citations (0)
P138 Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA)
2019
Journal of Crohns & Colitis
R W M Pauwels
C.J. van der Woude
D. Nieboer
Ewout W. Steyerberg
M.J Casanova
Javier P. Gisbert
Alan J. Lobo
C W Lees
N A Kennedy
T Molnár
K Szántó
Edward E. Louis
J-Y Mary
Milan Lukas
Marjolijn Duijvestein
Steven Bots
G. DHaens
A. C. de Vries
Show All
Source
Cite
Save
Citations (0)
P414 Ustekinumab endoscopic response at Week 16 is associated with early normalisation of faecal calprotectin after induction
2019
Journal of Crohns & Colitis
R W M Pauwels
A. C. de Vries
J C Goet
N S Erler
C.J. van der Woude
Show All
Source
Cite
Save
Citations (0)
P362 Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab
2019
Journal of Crohns & Colitis
R W M Pauwels
A. C. de Vries
J C Goet
N S Erler
C.J. van der Woude
Show All
Source
Cite
Save
Citations (0)
1
map